Evidence map›Paper›PMID 41847386›Full record

ReviewFrontiers in cell and developmental biology2026

Lamins' role in osteosarcoma.

Giulia Bagnato, Barbara Peruzzi

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giulia BagnatoDAHFMO - Unit of Histology and Medical Embryology, Sapienza University of Rome, Rome, Italy.
Barbara PeruzziDepartment of Life Science and Public Health, Section of Histology and Embryology, Catholic University of Sacred Heart, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma (OS) is a rare and highly aggressive bone tumor that can develop in several skeletal segments, although it predominantly affects the long bones. This cancer mostly occurs in adolescents, young adults and people older than 60. There are many questions still open regarding osteosarcoma biology and the efficacy of current treatments. Recent research has increasingly emphasized the critical role of mechanotransduction as a key regulator of cellular functions. Notably, emerging evidence highlights the nucleus as an active player in mechanosensing and mechanotransduction processes within the bone tissue. The nuclear envelope is composed of several proteins, among which lamins. These proteins are essential components of the inner nuclear membrane (INM) exerting many different functions, also known for having a pivotal role in mechanotransduction and bone cell differentiation. In this review, we analyze the state of the art regarding the lamins role in bone cancer biology.

Indexed as

bone tissuelaminsmechanotransductionnuclear envelopeosteosarcoma

Identifiers

PMID41847386
PMCPMC12989583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.